TOI Earnings — The Oncology Institute, Inc. Common Stock Post-ER Performance | BigEarnings
TOI — The Oncology Institute, Inc. Common Stock
XNAS · Healthcare · Medical Care Facilities
Price$4.69
Market Cap$468.9M
P/E—
52W Range$2.02 – $4.88
Next Earnings2026-08-12
About The Oncology Institute, Inc. Common Stock
The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.
